Larimar Therapeutics Stock Price on May 30, 2024
| LRMR Stock | USD 6.18 0.15 2.37% |
Below is the normalized historical share price chart for Larimar Therapeutics extending back to June 19, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Larimar Therapeutics stands at 6.18, as last reported on the 26th of November, with the highest price reaching 6.53 and the lowest price hitting 6.13 during the day.
If you're considering investing in Larimar Stock, it is important to understand the factors that can impact its price. Larimar Therapeutics has Sharpe Ratio of -0.0365, which conveys that the firm had a -0.0365% return per unit of risk over the last 3 months. Larimar Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Larimar Therapeutics' Standard Deviation of 5.53, risk adjusted performance of (0.02), and Mean Deviation of 4.04 to check out the risk estimate we provide.
As of 11/26/2024, Common Stock Shares Outstanding is likely to grow to about 46.1 M, while Total Stockholder Equity is likely to drop slightly above 73 M. . At this time, Larimar Therapeutics' Price Book Value Ratio is relatively stable compared to the past year. As of 11/26/2024, Price Earnings To Growth Ratio is likely to grow to 0.15, while Price To Operating Cash Flows Ratio is likely to drop (6.27). Larimar Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of June 2014 | 200 Day MA 8.1297 | 50 Day MA 7.2501 | Beta 0.713 |
Larimar |
Sharpe Ratio = -0.0365
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LRMR |
Estimated Market Risk
| 5.61 actual daily | 49 51% of assets are more volatile |
Expected Return
| -0.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Larimar Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Larimar Therapeutics by adding Larimar Therapeutics to a well-diversified portfolio.
Price Book 1.9811 | Book Value 3.109 | Enterprise Value 194.7 M | Enterprise Value Ebitda (4.13) | Shares Float 31.9 M |
Related Headline
Celcuity LLC Headline on 30th of May 2024
Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical ... by globenewswire.com
The Phase 3 clinical trial will evaluate gedatolisib plus a CDK46 inhibitor and fulvestrant as first-line treatment for patients with HRHER2- advanced...
Larimar Therapeutics Valuation on May 30, 2024
It is possible to determine the worth of Larimar Therapeutics on a given historical date. On May 30, 2024 Larimar was worth 7.15 at the beginning of the trading date compared to the closed value of 7.1. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Larimar Therapeutics stock. Still, in general, we apply an absolute valuation method to find Larimar Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Larimar Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Larimar Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 7.28 | 7.34 | 6.88 | 7.07 | 309,510 | |
05/30/2024 | 7.15 | 7.16 | 6.97 | 7.10 | 169,472 |
| 7.39 | 8.27 | 7.35 | 8.00 | 1,013,617 |
| Backtest Larimar Therapeutics | | | Larimar Therapeutics History | | | Larimar Therapeutics Valuation | Previous | Next |
Larimar Therapeutics Trading Date Momentum on May 30, 2024
| On May 31 2024 Larimar Therapeutics was traded for 8.00 at the closing time. The top price for the day was 8.27 and the lowest listed price was 7.35 . The trading volume for the day was 1 M. The trading history from May 31, 2024 was a factor to the next trading day price gain. The trading delta at closing time against the next closing price was 12.68% . The trading delta at closing time against the current closing price is 35.07% . |
Larimar Therapeutics Fundamentals Correlations and Trends
By evaluating Larimar Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Larimar Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Larimar financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Larimar Therapeutics Stock history
Larimar Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Larimar is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Larimar Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Larimar Therapeutics stock prices may prove useful in developing a viable investing in Larimar Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 43.9 M | 46.1 M | |
| Net Loss | -40.7 M | -42.7 M |
Larimar Therapeutics Quarterly Net Working Capital |
|
Larimar Therapeutics Stock Technical Analysis
Larimar Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Larimar Therapeutics Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Larimar Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Larimar Therapeutics November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Larimar Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Larimar Therapeutics shares will generate the highest return on investment. By undertsting and applying Larimar Therapeutics stock market strength indicators, traders can identify Larimar Therapeutics entry and exit signals to maximize returns
Larimar Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Larimar Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Larimar Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Larimar to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (1.05) | |||
| Treynor Ratio | (0.09) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Larimar Stock Analysis
When running Larimar Therapeutics' price analysis, check to measure Larimar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Larimar Therapeutics is operating at the current time. Most of Larimar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Larimar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Larimar Therapeutics' price. Additionally, you may evaluate how the addition of Larimar Therapeutics to your portfolios can decrease your overall portfolio volatility.